OrthoPediatrics (NASDAQ:KIDS) Shares Gap Up – What’s Next?

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $24.86, but opened at $25.51. OrthoPediatrics shares last traded at $25.28, with a volume of 7,053 shares.

Analysts Set New Price Targets

Several brokerages have issued reports on KIDS. Truist Financial cut their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Stifel Nicolaus cut their price target on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Wednesday, March 5th. Finally, Needham & Company LLC reissued a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research note on Wednesday, March 5th.

OrthoPediatrics Price Performance

The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $601.73 million, a P/E ratio of -20.15 and a beta of 1.22. The business’s 50 day moving average is $24.84 and its 200-day moving average is $25.37.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.04. The company had revenue of $52.67 million during the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same quarter in the prior year, the firm posted ($0.23) earnings per share. As a group, sell-side analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Insider Activity

In other news, insider Gregory A. Odle sold 5,359 shares of OrthoPediatrics stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $133,224.74. Following the completion of the sale, the insider now owns 148,788 shares in the company, valued at $3,698,869.68. The trade was a 3.48 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO David R. Bailey sold 6,620 shares of OrthoPediatrics stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $164,573.20. Following the completion of the sale, the chief executive officer now directly owns 319,155 shares of the company’s stock, valued at approximately $7,934,193.30. This trade represents a 2.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,732 shares of company stock valued at $589,978. 31.80% of the stock is currently owned by insiders.

Institutional Trading of OrthoPediatrics

Several large investors have recently made changes to their positions in KIDS. Millennium Management LLC acquired a new stake in OrthoPediatrics in the fourth quarter valued at approximately $9,798,000. Point72 Asset Management L.P. acquired a new stake in OrthoPediatrics in the 4th quarter valued at $7,450,000. Wasatch Advisors LP increased its stake in OrthoPediatrics by 47.2% during the 4th quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock valued at $16,141,000 after purchasing an additional 223,217 shares in the last quarter. Wellington Management Group LLP increased its stake in OrthoPediatrics by 20.2% during the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock valued at $24,601,000 after purchasing an additional 178,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in OrthoPediatrics by 29.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after buying an additional 152,681 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.